type 2 diabetes and semaglutide In a phase 3a study of adults with early-stage inadequately controlled with diet exercise, once-weekly cagrilintide–semaglutide reduced HbA1c vs placebo and was associated with body weight reductions over Semaglutide (Ozempic/Wegovy) shows 3-year efficacy

retail channels and may raise sourcing, labeling, and dietary concerns

For the vast majority of people, morning dosing produces the best results with the fewest complications

In addition, it has a positive effect on the differentiation of neural progenitor cells in hippocampus, proliferation, and long-term survival of neural progenitor cells (84, 96)

Accessed 5 Jan 2026

Methylene Blue: An Antidote for Methemoglobinemia and Beyond Methylene blue, a centuries-old medicinal treatment, is primarily known for countering acquired methemoglobinemia (MetHB)

The evidence STEP 1 randomised 1,961 adults with overweight or obesity to once-weekly semaglutide 2.4 mg or placebo for 68 weeks